Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal ...
The new fiscal year is already two days into its own ledger. On 2 October 2026, FDA issued a letter to Hanlim Pharm in Yongin ...
New Phase II/III study will evaluate ivonescimab plus chemotherapy against existing immunotherapy-based treatments, building ...
New CAS Connections integration combines over 150 years of curated scientific knowledge with CAS Newton’s agentic AI ...
Median 234 days from first CRO contact to site activation, range 74 to 657; median ethics approval 48 days, median governance ...
NeuroXT Inc., a medical device manufacturer, announced that NEXT-Cue, its AI-based Software as a Medical Device (SaMD) ...
The IMPACT31 trial will enrol 90 high-risk liver cancer patients across the US and Asia-Pacific to evaluate GNOS-PV02 ...
UK Collaboration to Explore Digital-First Screening for Early Detection of High Blood Pressure, Expanding Preventive ...
Medical device makers went digital to stay audit-ready. Yet their device history records are still being stitched together by ...
Oracle announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible ...
ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asia ...
HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results